Covidien has reached a definitive agreement to acquire Oridion Systems Ltd. Oridion, based in Jerusalem, Israel, develops Microstream® capnography monitors and modules, in conjunction with specialized algorithms, as well as etCO2 breath sampling lines.
“The acquisition of Oridion Systems adds a key monitoring technology to the Covidien portfolio,” said Robert J. White, president for Respiratory & Monitoring Solutions at Covidien. “Oridion’s products and etCO2 technology are excellent complements to the Company’s current portfolio of pulse oximeters and monitoring products, enabling us to offer a complete portfolio of solutions to monitor respiratory function for patients around the world.”
The companies expect to complete the merger in the second calendar quarter of 2012. Once the merger is complete, Covidien will report the Oridion Systems business as part of its oximetry and monitoring product line in the medical devices segment.